Monoclonal Antibody, Antibody Drug Conjugate, Small Molecule
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
488
NCT05278546
A Study of ILB2109 in Patients With Advanced Solid Malignancies
Phase: Phase 1
Role: Lead Sponsor
Start: Apr 11, 2022
Completion: Feb 28, 2025
NCT05955105
A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies
Phase: Phase 1/2
Start: Jul 25, 2023
Completion: Jul 24, 2026
NCT06426680
A Study of the ILB-3101 in Patients with Advanced Solid Tumors
Start: Oct 30, 2024
Completion: Mar 31, 2026
Loading map...